| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.06 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.07 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.07 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.07 |